A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

In an interview with Targeted Oncology, C. Ola Langren, MD, PhD, discussed the continuing impact of the groundbreaking FDA ...

Depth of response to isatuximab, carfilzomib, lenalidomide, and dexamethasone (Isa-KRd) in front-line treatment of high-risk multiple myeloma: Interim analysis of the GMMG-CONCEPT trial.

“There is no cure for multiple myeloma ... quantities of an abnormal immunoglobulin fragment, called a myeloma protein (M protein), causing kidney damage and impairing the patient’s immune ...

"We got to see how a college-level band would operate in a rehearsal. And it was really cool to get all this higher-level input from a college conductor. And performing with the U-M Symphony Band ...

Background: Multiple myeloma (MM) is a plasma cell malignancy with significant ... Also, we would like to thank Dr. Omar M. Hussein, Dr. Fady Adel, and Dr. Reham El-garhy for their guidance and follow ...

So here’s the deal: I’m a middle-aged white jam band fan, complete with an IPA gut and a sixth sense for finding the best garlic grilled cheese in any stadium or amphitheater parking lot. Need proof?

Dorritie, MD, discussed updated outcomes from the IsKia, MASTER, and CONCEPT clinical trials of frontline therapy in multiple myeloma. In this Community Case ... I think that now more and more I'm ...

Background: Multiple myeloma (MM) is a biologically heterogeneous malignancy of clonal plasma cells, often progressing from MGUS or smoldering MM. It causes anemia, bone lesions, and immune ...

Multiple myeloma represents an unmet need, emphasizing the significance of continued research and development in this field. Treatment with cemsidomide resulted in notable responses at multiple dose ...